Page last updated: 2024-09-05

organophosphonates and dronabinol

organophosphonates has been researched along with dronabinol in 2 studies

Compound Research Comparison

Studies
(organophosphonates)
Trials
(organophosphonates)
Recent Studies (post-2010)
(organophosphonates)
Studies
(dronabinol)
Trials
(dronabinol)
Recent Studies (post-2010) (dronabinol)
9,9688803,5968,3077853,094

Protein Interaction Comparison

ProteinTaxonomyorganophosphonates (IC50)dronabinol (IC50)
Cannabinoid receptor 1Rattus norvegicus (Norway rat)0.218
Cannabinoid receptor 1Homo sapiens (human)0.0028
Cannabinoid receptor 2 Homo sapiens (human)0.0095
Cannabinoid receptor 2Rattus norvegicus (Norway rat)0.218

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernando, SR; Pertwee, RG1
Goparaju, SK; Katayama, K; Kurahashi, Y; Suzuki, H; Ueda, N; Yamamoto, S1

Reviews

1 review(s) available for organophosphonates and dronabinol

ArticleYear
A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
    The journal of medical investigation : JMI, 1998, Volume: 45, Issue:1-4

    Topics: Amidohydrolases; Animals; Arachidonic Acid; Arachidonic Acids; COS Cells; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Esterases; Ethanolamine; Fatty Acids; Hydrolysis; Intestine, Small; Ligands; Liver; Nerve Tissue Proteins; Organ Specificity; Organophosphonates; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; Recombinant Fusion Proteins; Swine

1998

Other Studies

1 other study(ies) available for organophosphonates and dronabinol

ArticleYear
Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist.
    British journal of pharmacology, 1997, Volume: 121, Issue:8

    Topics: Animals; Arachidonic Acids; Clonidine; Dose-Response Relationship, Drug; Dronabinol; Guinea Pigs; In Vitro Techniques; Intestine, Small; Male; Muscle Contraction; Organophosphonates; Receptors, Cannabinoid; Receptors, Drug

1997